1. Safety, efficacy, and DIVA feasibility on a novel live attenuated classical swine fever marker vaccine candidate
- Author
-
Chao Tong, Huanhuan Liu, Jiaying Wang, Yanyong Sun, and Ning Chen
- Subjects
Classical Swine Fever ,Infectious Diseases ,General Veterinary ,General Immunology and Microbiology ,Classical Swine Fever Virus ,Swine ,Vaccines, Marker ,Public Health, Environmental and Occupational Health ,Animals ,Feasibility Studies ,Molecular Medicine ,Vaccines, Attenuated ,Biomarkers - Abstract
Classical swine fever virus (CSFV) is the etiological agent of classical swine fever, a highly contagious disease that causes significant economic losses to the swine industry. Systemic prophylactic immunization with the live attenuated vaccine, the C-strain vaccine, is one of the effective measures for CSF control. However, one of the limitations of the C-strain vaccine is that the field strains-infected animals cannot be differentiated from the C-strain vaccinated herds by serological tests (DIVA). This constraint hampers the practical usage of the C-strain vaccine to eradicate the CSF in China. In the current study, a novel CSF modified live marker vaccine candidate was constructed based on the attenuation of the prevalent 2.1 genotype strain by the deletion of two virulence associated functional residues in the CSFV E
- Published
- 2022
- Full Text
- View/download PDF